MRKR

1.09017.42%
MM

Maria-Bernadette Madel

Director of Corporate Operations & External Communications

Dr. Maria-Bernadette Madel, Ph.D., is Director of Corporate Operations & External Communications of Marker Therapeutics, Inc. from December 2023. Dr. Madel joined Marker Therapeutics, Inc in 2022 after accruing valuable experience in academic institutions, including Baylor College of Medicine. Dr. Madel earned a B.Sc. and M.Sc. in Molecular Medicine from the Medical University of Innsbruck, Austria and a Ph.D. in Immunology and Microbiology from the University Côte d’Azur, Nice, France.

Positions